T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.01B |
| 2 |
Broadcom
AVGO
|
+$1.49B |
| 3 |
GE Vernova
GEV
|
+$1.19B |
| 4 |
International Paper
IP
|
+$1.05B |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$952M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.31B |
| 2 |
Constellation Energy
CEG
|
+$1.94B |
| 3 |
Qualcomm
QCOM
|
+$1.74B |
| 4 |
NVIDIA
NVDA
|
+$1.71B |
| 5 |
Salesforce
CRM
|
+$1.5B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.98% |
| 2 | Healthcare | 14.89% |
| 3 | Financials | 10.35% |
| 4 | Consumer Discretionary | 10.11% |
| 5 | Communication Services | 9.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2401
Bowman Consulting
BWMN
$731M
| $301K | ﹤0.01% |
9,459
+1,034
| +12% | +$32.7K |
|
|
TPC
2402
Tutor Perini Cor
TPC
$4.98B
| $300K | ﹤0.01% |
13,771
+1,536
| +13% | +$28.2K |
|
|
KALV
2403
DELISTED
KalVista Pharmaceuticals
KALV
| $299K | ﹤0.01% |
25,352
+3,210
| +14% | +$37.5K |
|
2404
Clearfield
CLFD
$390M
| $298K | ﹤0.01% |
7,713
+177
| +2% | +$6.15K |
|
2405
Hertz
HTZ
$838M
| $298K | ﹤0.01% |
84,386
+9,537
| +13% | +$48.5K |
|
2406
The RealReal
REAL
$1.33B
| $298K | ﹤0.01% |
93,390
+15,190
| +19% | +$56K |
|
2407
Lightwave Logic
LWLG
$1.12B
| $296K | ﹤0.01% |
98,819
+15,391
| +18% | +$56.2K |
|
2408
Ardmore Shipping
ASC
$707M
| $295K | ﹤0.01% |
13,073
+1,139
| +10% | +$22.5K |
|
|
CVGW
2409
DELISTED
Calavo Growers
CVGW
| $295K | ﹤0.01% |
12,954
+135
| +1% | +$3.54K |
|
2410
Royal Bank of Canada
RY
$299B
| $295K | ﹤0.01% |
2,770
| – | – |
|
2411
Xeris Biopharma Holdings
XERS
$1.52B
| $295K | ﹤0.01% |
130,968
+5,333
| +4% | +$10.7K |
|
|
GRAL
2412
GRAIL Inc
GRAL
$3.05B
| $295K | ﹤0.01% |
+19,139
| New | +$310K |
|
2413
World Acceptance Corp
WRLD
$875M
| $294K | ﹤0.01% |
2,374
+45
| +2% | +$5.93K |
|
|
ONIT
2414
Onity Group
ONIT
$330M
| $294K | ﹤0.01% |
12,239
-4,103
| -25% | -$101K |
|
2415
Standard BioTools
LAB
$294M
| $293K | ﹤0.01% |
165,043
+96,174
| +140% | +$235K |
|
2416
NextDecade
NEXT
$1.8B
| $293K | ﹤0.01% |
36,792
+14,281
| +63% | +$98.4K |
|
2417
NN Inc
NNBR
$298M
| $293K | ﹤0.01% |
97,639
+14,848
| +18% | +$52K |
|
2418
Origin Bancorp
OBK
$1.69B
| $293K | ﹤0.01% |
9,237
+878
| +11% | +$26.9K |
|
2419
Fulgent Genetics
FLGT
$513M
| $292K | ﹤0.01% |
14,862
+601
| +4% | +$12.5K |
|
|
LAZR
2420
DELISTED
Luminar Technologies
LAZR
| $292K | ﹤0.01% |
13,060
+3,125
| +31% | +$74K |
|
2421
E.W. Scripps
SSP
$310M
| $292K | ﹤0.01% |
92,712
-4,450
| -5% | -$14.1K |
|
2422
SSR Mining
SSRM
$6.49B
| $292K | ﹤0.01% |
64,580
+18,256
| +39% | +$93.6K |
|
|
MITT
2423
TPG Mortgage Investment Trust
MITT
$214M
| $291K | ﹤0.01% |
43,743
+9,243
| +27% | +$59K |
|
2424
Universal Electronics
UEIC
$66.6M
| $291K | ﹤0.01% |
25,000
| – | – |
|
2425
Grid Dynamics Holdings
GDYN
$644M
| $289K | ﹤0.01% |
27,483
+1,937
| +8% | +$20K |
|
Similar funds
T. Rowe Price Associates's Q2 2024 Portfolio in Review
As of Q2 2024, T. Rowe Price Associates held 3,089 positions worth $836B, up 2.4% from $816B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
T. Rowe Price Associates's Q2 2024 filing shows 135 new, 1,850 increased, 836 reduced and 113 closed positions. Its largest new stake was Tempus AI: 5,227,120 shares worth $183M. The largest sale was Microsoft, an estimated $2.31B.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 32% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2024 buy was Tempus AI: 5,227,120 shares worth $183M.
- T. Rowe Price Associates added most to Apple in Q2 2024, an estimated $4.01B increase.
- T. Rowe Price Associates's biggest Q2 2024 reduction was Microsoft, cutting an estimated $2.31B.
- T. Rowe Price Associates fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $570M.
- T. Rowe Price Associates's ten largest holdings make up 36% of its $836B portfolio in Q2 2024.
- T. Rowe Price Associates opened 135 new positions and closed 113 in Q2 2024.
- T. Rowe Price Associates's portfolio value rose 2.4% quarter-over-quarter to $836B.
Based on T. Rowe Price Associates's 13F filing for Q2 2024, filed 14 Aug 2024.